| Study | Compared Approaches | Patients | Serum Markers | Results Biomarkers |
Other (pain, function, etc) |
Study Type |
|---|---|---|---|---|---|---|
| 1. Anterior approach versus posterior approaches | ||||||
| Difference in biomarkers | ||||||
| Bergin et al. (2011) [19] | Minimally invasive direct anterior (MIS-DA) vs minimally invasive posterior(MIS-PO) | MIS-DA: 29MIS-PO: 28 | CK, CRP, IL-6, IL-1b, TNF-a | MIS-DA: Lower levels of all markers | MIS-PO: Significant higher operative time and incision length | PRCS |
| Zhao et al. (2017) [41] | Anterior (DAA) vs Postero-lateral (PLA) | DAA: 60 PLA:60 |
CRP, ESR, IL-6 | DAA: Lower levels of all markers the first 4 POD | DAA: Better HHS, UCLA in 3 months | RCT |
| Poehling-Monaghan et al. (2017) [42] | Anterior (DAA) vs Mini Posterior (MPO) | DAA: 50 MPO: 50 |
CK, myoglobin, CRP, TNFa, IL-6 | DAA: Lower levels of all markers with MPA | Pain scores: No significant difference | PRCS |
| No difference in biomarkers | ||||||
| Pilot et al. (2006) [37] | Minimal invasive direct anterior (MIS-DA) vs Postero-lateral (PLA) | MIS-DA: 10 PLA: 10 |
H-FABP, myoglobin, CK, ASAT, LDH, IL-6, IL-10 | No significant differences between the groups | MIS-DA: Higher blood loss (not significant), Longer operative time | PRCS |
| Rykov et al. (2017) [43] | Anterior (DAA) vs Postero-lateral (PLA) | DAA: 23 PLA: 23 |
CK, CRP | No significant differences between the groups | HHS, HOOS: Similar | RCT |
| 2. Anterior approach versus lateral approaches | ||||||
| Difference in biomarkers | ||||||
| De Anta-Díaz et al. (2016) [44] | Anterior (DAA) vs Lateral (LA) | DAA: 49 LA: 50 |
IL-1, IL-6, IL-8, IL-10, IL-12, TNF, CK, ESR, CRP | DAA: Lower levels of biomarkers | MRI: Less soft tissue damage HHS: Similar results |
RCT |
| Nistor et al. (2017) [45] | Anterior (DAA) vs Lateral (LA) | DAA: 35 LA: 35 |
Myoglobin, CK, LDH | DAA: Lower levels of myoglobin CK and LDH: No significant difference |
DAA: Less pain the 1st POD | RCT |
| Mjaaland et al. (2015) [46] | Minimally invasive direct anterior (MIDA) vs direct lateral (LA) | MIDA: 83 LA: 80 |
CK, CRP | LA: Lower CK levels in 4th POD | MIDA: Less pain | RCT |
| 3. Anterolateral versus other approaches | ||||||
| Difference in biomarkers | ||||||
| Mouilhade et al. (2010) [47] | Minimally invasive antero-lateral (Watson-Jones) approach (MIS-AL) with an AL approach with anterior hemimyotomy | MIS-AL: 92 AL-HM: 49 | Myoglobin, CPK | MIS-AL: Lower of CPK at 1st and 2nd POD | MIS-AL: Better functional outcomes at 6 weeks. Less variation of cup inclination. | PRCS |
| Inaba et al. (2011) [48] | Modified Watson-Jones (M-AL) vs modified mini-incision direct lateral approach (MIS-LA). | M-AL: 57 MIS-LA: 60 |
CRP, CK | M-AL: Lower CK levels at 1st POD | Pain and functional outcome: No notable difference | RCT |
| Muller et al. (2011) [20] | Minimally invasive anterolateral (MIS-AL) vs modified direct lateral approach (M-LA). | MIS-AL: 21 M-LA: 16 |
CK, myoglobin | MIS-AL: Lower CK levels at 6 hours and 1st POD | MIS-AL: Less muscle damage | RCT |
| Matziolis et al. (2011) [49] | Minimally invasive anterolateral (MIS-AL) vs minimally invasive transgluteal (MIS-TG) | MIS-AL: 20 MIS-TG: 20 |
sTnI | MIS-AL: Lower levels of sTnl the 1st POD | Similar: Hospitalization, blood loss and complications | RCT |
| No difference in biomarkers | ||||||
| Landgraeber et al. (2013) [50] | Minimally invasive anterolateral (MIS-AL) vs conventional lateral (LA) | MIS-AL: 36 LA: 40 |
CK, CRP | No significant difference | Functional outcomes and pain: No significant difference.MISAL: Longer operating time and greater blood loss | RCT |
| 4. Posterior approach versus minimally invasive posterior approach | ||||||
| Difference in biomarkers | ||||||
| Suzuki et al. (2004) [51] | Conventional posterolateral (PLA) vs minimally invasive posterolateral (MIS-PLA) | PLA: 39 MIS-PLA: 61 |
CRP, ESR, CPK | MIS-PLA: Lower CRP and ESR levels at 1st week CPK levels: No significant difference |
MIS-PLA: Shorter operative time, lower blood loss, less hospital stay. Functional outcomes: Similar |
PRCS |
| Kwak et al. (2014) [40] | Conventional posterolateral (PLA) vs minimally invasive posterolateral (MISPLA) | PLA: 15 MIS-PLA: 15 |
CK, IL-6, IL-8, IL-10, IL-1, aldol-se | MISPLA: Lower levels of CK, IL-6, IL-10, IL-1 at 1st and 3rd POD and IL-8 at 7th POD | MIS-PLA: Less blood loss | PRCS |
| No difference in biomarkers | ||||||
| Fink et al. (2010) [52] | Conventional posterolateral (PLA) vs minimally invasive posterolateral (MIS-PLA) | PLA: 50 MIS-PLA: 50 |
CPK, CK-MM, myoglobin, CRP | No significant differences | MIS-PLA: Lees pain, lower blood loss, less hospital stay | PRCS |
| 5. Lateral approach versus minimal incision lateral | ||||||
| Mazoochian et al. (2009) [53] | Standard lateral (LA) vs minimally invasive lateral approach | LA: 26 MIS-LA: 26 |
CK, myoglobin | MIS-LA: Statistically lower myoglobin levels at 6 h postoperatively | MIS-LA: Shorter operating time, less blood loss and better functional results (HHS- 6 weeks and 3 months) (WOMAC-3 months) | RCT |
| Dienstknecht et al. (2014) [54] | Conventional lateral, transgluteal approach (Bauer) (LA) vs mini-incision (MIS-LA) | LA: 88 MIS-LA: 55 |
CK, CRP | No significant difference | MIS-LA: Lower VAS pain all POD / Shorter operative time | RCT |
| 6. Standard lateral and postero-lateral versus minimally invasive lateral and posterolateral | ||||||
| Shitama et al. (2009) [55] | Conventional lateral (LA), Conventional or postero-lateral (PLA) vs minimally invasive lateral (MIS-LA) and posterolateral (MIS-PLA) | LA: 8 PLA: 20 MIS-LA: 15 MIS-PLA: 19 |
IL-6, CRP | No significant different | Shorter operative time with the standard group | RCT |
| Goosen et al. (2011) [56] | Conventional lateral (LA), Conventional or postero-lateral (PLA) vs minimally invasive lateral and posterolateral | LA: 20 PLA: 20 MIS-LA: 20 MIS-PLA: 20 |
CK, Myoglobim | No significant difference | Shorter operative time with the standard group | Double- blind RCT |
| 7. Three different MIS approaches | ||||||
| Cohen et al. (2009) [57] | Modified Watson Jones (MIS-AL), vs minimally invasive posterior (MIS-I) vs minimally invasive two incision (MIS-II) | MIS-AL: 10 MIS-I: 10 MIS-II: 10 |
CK, CPK, myoglobin | No significant different | Smaller duration of surgery and lower rates of blood loss with MIS-AL | COS |